Principal Securities »

Silence Therapeutics shares owned by Principal Securities

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Principal Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $88 17 5.18
2025-06-30 $98 17 5.82

More positions owned by Principal Securities

Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Principal Exchange Traded Focused Blue Chi (BCHP)
Principal Exchange Traded Prin U S Small (PSC)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Microsoft Corporation (MSFT)
Principal Exchange Traded Intl Equity Etf (PIEQ)
Ishares Tr Core S&p Us Vlu (IUSV)
Spdr Series Trust Portfolio S&p500 (SPLG)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Principal Exchange Traded Prnc Invt Grad (IG)
Ishares Tr Rus 1000 Etf (IWB)

View all positions for Principal Securities

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Lombard Odier Asset Management
Morgan Stanley
Vivo Capital
Nantahala Capital Management
Frazier Life Sciences Management
Nextech Invest
Ikarian Capital
Cantor Fitzgerald, L. P.
5AM Venture Management
SG Americas Securities
UBS Group
Millennium Management

View all funds holding Silence Therapeutics